Serva Energy was featured recently in a new podcast from Drug Discovery News (DDN) highlighting the history of Actinium-225 and its...

Serva Energy’s collaboration with the University of California—Irvine Nuclear Reactor Facility was highlighted in a recent news story...

NEWS RELEASE November 1, 2023 Serva Energy’s sample measurement of the rare, cancer-killing medical isotope Actinium-225 has been...

Nuclear innovation was the focus of a Nuclear Science Week national expo event, Saturday, Oct. 14, with the University of...

Partnership aims to ‘revolutionize’ isotope production in Canada Serva Energy has partnered with the Canadian Nuclear Isotope Council...

NEWS RELEASE June 22, 2023 Tempe, AZ — Serva Energy, a nuclear innovation company, has developed a new production method to ramp up the...

This week we are headed to the University of Maryland in College Park, Maryland, for the TRTR and IGORR Research Reactor Conference. Dr....

U.S. support for nuclear power has reached the highest level in a decade, according to a new Gallup survey released last month....

Recent investments in nuclear infrastructure focus on the growing demand for medical isotopes, including Actinium-225, the focus of our...

At Serva Energy, we all know that nuclear power is one of the safest, cleanest forms of energy, but most people might not feel that way....

PRESS RELEASE November 14, 2022 "Challenge Accepted" is the fitting theme of the 2022 American Nuclear Society (ANS) Winter Meeting and...

“American competitiveness in science and innovation relies, to a great extent, on the development and production of key isotopes, and...

Check out our latest newsletter to find out what we've been up to! Interested in subscribing? Join our mailing list!

PRESS RELEASE October 7, 2022 Serva Energy has been selected as a semi-finalist by the Arizona Commerce Authority for the 2022 Arizona...

PRESS RELEASE September 27, 2022 “This is an exciting time for the biomedical research community and nuclear medicine, in particular,”...

The threat of climate change and the unreliability of electrical grids, in addition to growing fears about national security, are...

Serva Energy is one of 32 biotechnology and medical technology companies selected to participate in the White Hat Life Science Investor...

“Nuclear energy is at an inflection point,” writes Catherine Clifford in an August 3 article for CNBC, due to promising new technology...

The nuclear innovation company TerraPower, co-founded by Bill Gates, announced $750 million in new funding this week to develop nuclear...

Get the latest news from Serva Energy by subscribing to our bimonthly newsletter — it's free and gets delivered to your inbox every other...